Dr. Peter Kayatz
Inhaber, Business Coach & Interim Manager, Waterbergh Management e.U.
Oetz, Österreich
Werdegang
Berufserfahrung von Peter Kayatz
Bis heute 4 Jahre und 6 Monate, seit Okt. 2019
Founder & CEO
Stams Diagnostics GmbH
Bis heute 4 Jahre und 7 Monate, seit Sep. 2019
Member of the Board
INiTS Universitäres Gründerservice Wien GmbHBis heute 6 Jahre, seit Apr. 2018
Board Member
Regenta Pharmaceuticals
Bis heute 6 Jahre und 4 Monate, seit Dez. 2017
Member Advisory Board
Alpine Quantum Technologies
Bis heute 9 Jahre und 1 Monat, seit März 2015
Lecturer in Financial Planning & Management
UFL - Private University of the Principality of Liechtenstein
Bis heute 15 Jahre und 10 Monate, seit Juni 2008
Business Coach & Interim Manager
Waterbergh Management e.U.
Certified Interim Manager with proven achievements in change management, coaching & training, fundraising and financing (public & private), business development, partnering, licensing, as well as in conducting due diligence for venture capital firms. - My experience is your Peace of Mind! Specialties: Business planning, licensing, financing, negotiations between entrepreneurial companies and large multinational companies.
2012 - 2019
Member Advisory Board
tech2b Inkubator GmbH
Science4Life is an independent start-up initiative that offers consulting, support and further education for young companies in the life sciences, chemistry and energy sectors throughout Germany free of charge. It was founded in 1998 as a non-profit organization and has been an association since 2003. Initiators and sponsors are the Hessian state government and the health company Sanofi.
2015 - 2015
Coach & Panellist at the Ingite Training Program for Entrepreneurship
Cambridge Judge Business Schoolgnite is an intensive, one-week training program for aspiring entrepreneurs and corporate innovators to trial and prepare business ideas for the commercial environment. Peter was invited by the program manager of Ignite to contribute in form of one-to-one coachings (expert clinics) and joining the final pitching panel.
2 Jahre und 2 Monate, Sep. 2008 - Okt. 2010
Board Member
peakfactor
Shareholder and Coach
5 Jahre und 3 Monate, März 2003 - Mai 2008
Interim Managing Director
AlcaSynn Pharmaceuticals
Interim Managing Director of Star-up Company (Ltd) Set up of Organisation Acquisition of Grants and Soft Loans > 1 Mio. € Acquisition of Corporate Venture Capital > 10 Mio. €. - Trade Sale to Sanochemia Pharmazeutika, Vienna, in 2006.
2008 - 2008
Board Member
Axon Neuroscience
1 Jahr und 6 Monate, Okt. 2002 - März 2004
Incubation Manager
CAST Center for Academic Spin-offs Tyrol
Portfolio management, interim management, venture development, fund raising.
2 Jahre und 9 Monate, Feb. 2000 - Okt. 2002
Venture Capital Advisor
IVP Innovations & Venture Partners (now "Concentro")
Head of the Competence Center Life Sciences, - Consulting of venture capital firms, venture screen, due diligence, start-up consulting, acquisition of venture capital, interim management
7 Monate, Okt. 2001 - Apr. 2002
Interim Manager
Roche Innovatis
Redesign and setup of organizational structure, workflow management and product development, subsequent to a growth financing by Ventizz Capital Partners, Düsseldorf. - Innovatis was sold to Roche in 2009
10 Monate, Apr. 2000 - Jan. 2001
Interim Investment Manager
IMH - Industrie Management Holding
Interim Investment Manager Life Sciences- venture screen and evaluation, management presentations, due diligence, investment proposal. - Today, the IMH-Funds are managed by Triginta.
Ausbildung von Peter Kayatz
2000 - 2001
Postgraduate 'BioBusiness'
University of Heidelberg
Management of high-tech companies, accounting, financing & valuation, controlling, patenting & licensing
1999 - 1999
Postgraduate 'Medical Biometry'
University of Heidelberg
Methods for the descriptive and analytical biostatistics and the interpretation thereof.
1997 - 1999
Cell Biology
Technical University Aachen (RWTH)
Development of the first electron microscopic technique for the ultra structural localization of lipid peroxides. Publication in 'Methods of Enzymology'
1997 - 2000
Ophthalmology
University of Cologne, Medical School
Investigations regarding the pathogenesis of AMD (age related macular degeneration), with focus on the processing of peroxidized lipids and proteins in the retina of rats. A total of 11 scientific full papers. There of two first Author Papers in 'Invest Ophtalmol Vis Sci'
1 Jahr und 2 Monate, Juni 1993 - Juli 1994
Diploma Thesis - Protein Chemistry
Diabetes Research Institute, Duesseldorf
'Signal transduction of the insulin receptor – investigation of the autophosphorylation sites of the intra cellular domain of the insulin receptor'
1987 - 1994
University Degree in Biology
University of Cologne
Advanced courses in biochemistry, molecular genetics, organic chemistry, botanic Grants by Bayer AG and Carl-Duisberg-Foundation
Sprachen
Deutsch
Muttersprache
Englisch
Fließend
Spanisch
Grundlagen
Klartext
-